How has venture capital professionalized over the years?

Venture capital has evolved from a 'cottage industry' of a dozen people making decisions to a professionalized sector with larger operating teams. These teams now help founders with talent, go-to-market strategies, and product development, benefiting entrepreneurs through increased support.

What is Sequoia Capital's strategy regarding China investments?

Sequoia has separated its China business into an independent entity called Hongchan due to increasing geopolitical divisions and regulatory uncertainty. While Chinese entrepreneurship remains strong, operating conditions for foreign investors have become challenging.

What are the key characteristics Sequoia looks for in partners?

Sequoia prioritizes insatiable curiosity and individuals who are extremely driven but also possess a 'heart of gold'. They value both individualism for unique insights and teamwork for collaborative decision-making and executing investments.

Why does Sequoia Capital invest in companies long after their IPO?

Sequoia believes that great companies can continue to compound value for decades, even as public entities. By holding shares in their 'Sequoia Capital Fund' post-IPO, they allow these companies to grow further, generating significant additional gains for their limited partners.

What is Don Valentine's founder matrix?

Don Valentine's matrix categorizes founders into four quadrants based on whether they are exceptional or not, and whether they are easy or difficult to get along with. Sequoia typically makes money on exceptional founders who might be difficult, as they are the ones who challenge the status quo and change the world.

What are the key lessons Roelof learned from his mentors, Doug Leone and Michael Moritz?

Roelof learned 'heart' from Doug Leone, illustrated by his unwavering support during tough personal and professional times. From Michael Moritz, he learned the importance of 'imagination', particularly in recognizing the long-term potential of companies beyond their initial offerings.

What is Sequoia's experience with life sciences and biotech investing?

Sequoia has had success with a diagnostics company called Natera, but generally lacks specific expertise in biotech due to not having MD PhDs on their team. They acknowledge the risks of entering domains without deep understanding and respect those who do.

Sequoia’s Roelof Botha: Why Venture Capital is Broken & How Great Companies Are Built

All-In Podcast

Entertainment4 min read28 min video

Oct 9, 2025|99,445 views|1,354|51

chamath david sacks david friedberg jason calacanis all in podcast tech news politics election stocks stock market palihapitiya

Save to Pod

Key Moments

TL;DR

Sequoia's Roelof Botha discusses VC's excess capital problem, cultural values, and building enduring companies.

Key Insights

The venture capital industry suffers from too much capital chasing too few great companies, leading to unsustainable return expectations.

Sequoia fosters a culture of insatiable curiosity, driven individuals with strong ethics, and collaborative decision-making where consensus is paramount.

The firm's 'Sequoia Capital Fund' allows them to hold onto successful public company shares, capturing long-term value creation beyond traditional exit timelines.

Adapting to macro changes, Sequoia separated its China business and leverages technology internally to enhance investor and founder support.

Great founders are often unconventional and driven by a profound imagination and resilience, embodying a spirit that challenges the status quo.

Mentorship from veterans like Doug Leone (heart) and Michael Moritz (imagination) has been crucial to Roelof's leadership and Sequoia's enduring success.

THE SEVEN-FIGURE SCOUT PROGRAM AND EARLY SUCCESSES

Roelof Botha begins by discussing the genesis and success of Sequoia's Scout program, launched in 2010. The program empowered contemporary founders, lacking personal capital but possessing keen insights into emerging startups, to invest. These scouts, like Jason Calacanis and Sam Altman, provided valuable introductions and early investments, including Uber and Stripe. The first cohort of scouts generated exceptional returns, with funds achieving over 20x multiples, highlighting the program's initial impact and setting a high bar for future endeavors.

THE VENTURE CAPITAL INDUSTRY'S CAPITAL GLUT PROBLEM

Botha identifies a critical issue in the venture capital industry: an excessive amount of capital chasing a limited number of truly exceptional companies. With $150-$200 billion invested annually, the math suggests the industry needs over a trillion dollars in exit values yearly to meet reasonable return expectations. However, historical data shows only about 20 companies globally achieve billion-dollar exits each decade. This imbalance creates a 'return-free risk,' where more money doesn't necessarily generate more great ideas or founders.

ADAPTATION AND STRATEGIC SEPARATION IN A GLOBAL LANDSCAPE

Sequoia has navigated evolving global dynamics by adapting its strategy, notably through the separation of its China business into an independent entity, Hongchan. This move was prompted by increasing geopolitical divisions and regulatory uncertainty, making global integration difficult. The reduction in startup formation in China, from 51,000 in 2018 to 1,200 in 2023, underscores the challenges entrepreneurs face with unstable regulations. This serves as a cautionary tale for AI policy in the U.S., emphasizing the need for founder confidence.

SEQUOIA'S UNIQUE CULTURE AND EMPOWERING INTERNAL TOOLS

Sequoia's culture is built on insatiable curiosity, driven individuals, and a strong ethical compass, fostering both individualism and teamwork. Investment decisions are made by consensus, requiring unanimous agreement, which ensures thorough deliberation and accountability. The firm differentiates itself by not growing its external operating teams excessively. Instead, it invests in internal technology, such as an AI-powered business plan summarizer and data analytics tools, empowering investors with deep insights into companies and their competitive landscapes.

THE STRATEGIC ADVANTAGE OF HOLDING WINNERS AND THE SEQUOIA CAPITAL FUND

Recognizing that significant value creation occurs long after IPO, Sequoia launched the Sequoia Capital Fund. This structure allows the firm to hold shares in successful public companies, enabling continued value compounding. Historically, companies like Apple, NVIDIA, and Google, backed by Sequoia, now constitute over 30% of the NASDAQ's value. By moving shares into this fund post-IPO, Sequoia has generated billions in additional gains approximately six to eighteen months later, preventing premature capital distribution to LPs who might otherwise sell too early.

THE ESSENCE OF GREAT FOUNDERS AND THE POWER OF IMAGINATION

Roelof Botha reflects on the characteristics of great founders, drawing from Don Valentine's matrix of exceptional, difficult-to-get-along-with individuals. These founders are often unconventional, resilient, and possess a unique ability to imagine a different future, refusing to accept limitations. Mentors like Michael Moritz demonstrated this through his foresight with companies like Twitter and Yelp. This relentless drive and visionary thinking are essential for building world-changing companies, often requiring a departure from conventional traits.

LEGACY MENTORSHIP AND THE VALUE OF INTERGENERATIONAL KNOWLEDGE

Botha emphasizes the profound impact of his mentors, Doug Leone and Michael Moritz. Doug instilled the importance of 'heart,' demonstrating unwavering support during challenging times, while Michael's gift was 'imagination,' the ability to foresee a company's grand potential. Although both have transitioned from daily operations, their influence persists through intergenerational knowledge transfer. Botha actively seeks their counsel, valuing their deep experience and unique perspectives, which remain critical to Sequoia's ongoing stewardship and decision-making.

LIFE SCIENCES INVESTING: A NICHE FOR SPECIALIZED EXPERTISE

While Sequoia has achieved remarkable success in diagnostics and genetic testing, notably with their investment in Natera, Botha acknowledges the firm's limitations in deep biotech investing. Lacking MD PhDs on the team, Sequoia considers it dangerous to venture into domains without specialized expertise. The firm has made select investments in rare genetic disease drug development, like Bridge Bio, but primarily focuses on areas where its core venture capital strengths align with technical understanding, respecting the boundaries of different scientific fields.

Mentioned in This Episode

●Products

●Software & Apps

●Companies

●People Referenced

Venture Capital Fund Multiples

Data extracted from this episode

Fund Name	Notable Investments	Multiple
Venture 12	Airbnb, Dropbox, Nera, ADM Mob	North of 20x
Venture 13	Stripe, Block (formerly Square)	North of 20x

Common Questions

Roelof Botha argues that there is too much money in the venture capital industry, leading to a 'return-free risk'. This excess capital makes it difficult to generate adequate returns, as the number of successful billion-dollar exits does not scale with the amount of money invested.

Topics

Startup Investing Sequoia Capital Founder Psychology Early-stage Investing Life Sciences Biotech IPO

Mentioned in this video

personRoelof Botha

The CEO and managing partner of Sequoia Capital, who is the main speaker in the video, discussing venture capital trends and Sequoia's strategies.

companyNatera

A diagnostics company that Sequoia invested in with a seed round of $1 million in 2007, which has since grown to a $22 billion market cap.

personDon Valentine

Founder of Sequoia Capital, known for his insights on founders and his development of a four-quadrant matrix to identify successful entrepreneurs.

companyPalo Alto Networks

A cybersecurity company that was incubated within Sequoia's offices, highlighting their deep involvement from early stages.

personMichael Moritz

Former managing partner at Sequoia Capital, credited with nurturing his imagination and influencing Roelof Botha's investment perspective.

companyBridge Bio

A company focused on rare genetic disease drug development in which Sequoia has made an investment.

toolBlock

softwareCash App

toolGeneral Catalyst

Found this useful? Build your knowledge library

Get AI-powered summaries of any YouTube video, podcast, or article in seconds. Save them to your personal pods and access them anytime.

Try Summify free